| Revenue growth | Up 39.5% YoY to ₹11,223 million; 5.6% sequential growth. |
|---|---|
| Margins | EBITDA margin 16.7%; impacted by 150 bps wage hike. |
| Order book | 9 major deal wins >$1M; healthy pipeline for H2. |
| Demand visibility | Strong, record drug approvals and clinical pipelines globally. |
| Management confidence | Confident, shifting from optimism to evidence of AI-driven scale. |
Growth
Revenue grew 39.5% YoY to $117.5M; top 20 accounts grew 6.7% sequentially in INR terms.
Outlook
Management targets 19% plus EBITDA margins by Q4 FY27; H2 FY27 growth expected to exceed H1.
Risks
EBITDA margin pressured by wage hikes; customer concentration remains significant with top 10 contributing 49%.
Earnings Call Transcript filed with BSE, NSE: INDGN. Summary written with AI assistance from the document.
Indegene Ltd: key numbers
- Share price
- ₹586.80
- Market cap
- ₹14,138 Cr
- Revenue (annual)
- ₹3,510 Cr
- Net profit (annual)
- ₹401.1 Cr
- P/E (TTM)
- 34.4×Sector 52.8×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 12.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indegene Ltd
All →Indegene Management Change
Indegene's Company Secretary and Compliance Officer Srishti Ramesh Kaushik resigned, effective 02-Dec-2026. The resignation cites future career advancement.
Indegene Employee Stock Options
Indegene Limited allotted 52,194 equity shares under its ESOP schemes, raising paid-up capital to Rs.48.21 Crore. No cash fund raise is involved, so no event value applies.
Indegene Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 11,223M (+39.5% YoY, +5.6% QoQ), EBITDA margin 16.7%, PAT INR 1,123M (+10% YoY). BioPharm integration ahead of plan.
Indegene Results Update
Indegene reported Q2 FY27 revenue of ₹11,223M, up 39.5% YoY, with PAT of ₹1,123M. H1 USD revenue growth reached a four-year high of 27.0%.
Indegene Q2 FY27 Results: Net Profit ₹112.3 Cr, Up 10.0% YoY
Indegene Ltd reported revenue from operations of ₹1,122 Cr (+39.6% YoY) and net profit of ₹112.3 Cr (+10.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹112.3 Cr · +10.0% YoY
Indegene Merger & Restructuring
Indegene Ltd disclosed that its step-down wholly owned subsidiary, Indegene Portugal Unipessoal LDA, was incorporated on 23 October 2026. The entity has nil turnover and is yet to begin operations.